PeptoPro®, the award winning casein hydrolysate from DSM, has been selected by sports nutrition giant VPX to feature in two exclusive muscle building supplements. NO-Shotgun® v.3 and NO-SyntheSize® v.3 will revolutionize the resistance training segment of the sports nutrition market.

NO-Shotgun v.3 is a potent muscle energy catalyst which can be mixed with water or any soft beverage and is designed for consumption prior to or during exercise and post exercise. Reformulated with the addition of PeptoPro, it rapidly delivers peptides to the bloodstream, resulting in high levels of amino acids and increased insulin production. Insulin, not testosterone, is the most important ‘muscle building’ hormone of all hormones. As a result, when NO-Shotgun v.3 and NO-SyntheSize v.3  is consumed in conjunction with intense resistance training, athletes are able to endure a more rigorous workout and increase muscle growth during the recovery period.

Developed to be consumed during a workout and also for post workout consumption, NO-Synthesize also contains PeptoPro as well as a variety of other ingredients such as COP , GBB  etc. for continued muscle recovery and growth. A similar formulation, minus the energy inducing stimulant, NO-Synthesize uses PeptoPro as an integral catalyst in muscle growth during the recovery period. Also available in a soluble powder format, NO-SyntheSize is simple to use and almost instantly effective.

Jack Owoc, CEO and Chief Scientific Officer of VPX, comments: “VPX has developed many cutting edge supplements that have been consumed by millions of workout enthusiasts. However, we believe we have struck gold with the exclusive Shotgun and Synthesize product formulations. We selected PeptoPro because it is clinically proven to rebuild muscle after exercise. Its insulinotropic effect is indisputable – not only is its efficacy in aiding muscle growth and recovery backed up with extensive scientific evidence, the results are also noticeable. PeptoPro along with other revolutionary ingredients like DiNa Creatine Phosphate Tetrahydrate provides additional functionality that propel NO-Shotgun and NO-SyntheSize light years ahead of other products in this sector.”

PeptoPro is a peptide based on natural milk protein. Due to its unique composition containing small chains of di- and tri-peptides, it can be fully and rapidly absorbed by the body without adversely affecting the digestive system. Its amino acids are therefore made available to the muscles considerably faster than if conventional sources of protein are consumed.

NO-Shotgun and NO-SynthSize are available online at www.vpx1.com, as well as GNC, Vitamin Shoppe, and Vitamin World stores across the United States.
ENDS

DSM – the Life Sciences and Materials Sciences Company
DSM creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam.

For further information on PeptoPro® please contact: DSM Nutritional Products. Tel: (800) 526-0819 Fax: (973) 257-8420 E-mail: webshop.dnpna@dsm.com Or visit  http://www.peptopro.com/

Forward-looking statements
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM management and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.